|
29
|
113
|
7ms7A |
Structure of usp5 zinc-finger ubiquitin binding domain co-crystallized with (5-((4-(4-chlorophenyl)piperidin-1-yl)sulfonyl)picolinoyl)glycine |
|
85
|
305
|
7nt2A |
Crystal structure of sars cov2 main protease in complex with fsp006 |
|
79
|
305
|
7ntvA |
Crystal structure of sars cov2 main protease in complex with dn_eg_002 (modelled using pandda event map) |
|
85
|
346
|
7n33A |
Sars-cov-2 nsp15 endoribonuclease pre-cleavage state |
|
89
|
348
|
5sahA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with en300-100112 |
|
94
|
348
|
5sa4A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z239136710 |
|
74
|
260
|
6z7vA |
Crystal structure of mindy2 (c266a) in complex with lys48 linked di-ubiquitin (k48-ub2) |
|
92
|
348
|
5sa8A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z68299550 |
|
90
|
348
|
5saiA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z1424343998 |
|
90
|
348
|
5saeA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z3219959731 |
|
91
|
348
|
5sa5A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z1530301542 |
|
92
|
348
|
5saaA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z319891284 |
|
23
|
116
|
7eq4A |
Crystal structure of the n-terminus of nonstructural protein 1 from sars-cov-2 |
|
90
|
348
|
5sa7A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z1673618163 |
|
90
|
348
|
5sagA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with en300-1605072 |
|
92
|
348
|
5sa9A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z2697514548 |
|
91
|
348
|
5safA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with en300-321461 |
|
88
|
348
|
5sa6A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z2856434783 |
|
93
|
305
|
7djrA |
Crystal structure of sars-cov-2 main protease (no ligand) |
|
91
|
348
|
5sadA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z425449682 |
|
92
|
348
|
5sacA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z59181945 |
|
78
|
278
|
7exmA |
The n-terminal crystal structure of sars-cov-2 nsp2 |
|
89
|
348
|
5sabA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z31504642 |
|
86
|
306
|
7bajA |
Crystal structure of ligand-free sars-cov-2 main protease |
|
91
|
300
|
7balA |
Crystal structure of sars-cov-2 main protease treated with ebselen derivative of mr6-31-2 |
|
87
|
304
|
7bakA |
Crystal structure of sars-cov-2 main protease treated with ebselen |
|
182
|
635
|
7mswA |
Full length sars-cov-2 nsp2 |
|
157
|
502
|
7msxA |
Sars-cov-2 nsp2 |
|
87
|
306
|
7mrrA |
Crystal structure of sars-cov-2 main protease (3clpro/mpro) in complex with covalent inhibitor leupeptin |
|
29
|
131
|
7diyA |
Crystal structure of sars-cov-2 nsp10 bound to nsp14-exoribonuclease domain |
|
66
|
286
|
7diyB |
Crystal structure of sars-cov-2 nsp10 bound to nsp14-exoribonuclease domain |
|
71
|
306
|
7mhnA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 277 k |
|
95
|
315
|
7oftA |
Structure of sars-cov-2 papain-like protease plpro in complex with p-hydroxybenzaldehyde |
|
96
|
315
|
7ofuAAA |
Structure of sars-cov-2 papain-like protease plpro in complex with 3, 4-dihydroxybenzoic acid, methyl ester |
|
71
|
306
|
7mhqA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 310 k |
|
91
|
315
|
7ofsA |
Structure of sars-cov-2 papain-like protease plpro in complex with 4-(2-hydroxyethyl)phenol |
|
67
|
306
|
7mhoA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k |
|
78
|
306
|
7mhmA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 240 k |
|
88
|
306
|
7mngA |
Crystal structure of sars-cov-2 main protease (3clpro/mpro) in complex with covalent inhibitor vby-825 (partial occupancy) |
|
85
|
303
|
7mpbA |
Sars coronavirus-2 main protease 3cl-pro binding ascorbate |
|
84
|
306
|
7mhkA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 310 k |
|
82
|
306
|
7mhiA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k |
|
70
|
303
|
7lcqA |
N-terminal finger stabilizes feline drug gc376 in coronavirus 3cl protease |
|
83
|
306
|
7mhjA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k and high humidity |
|
89
|
306
|
7mhgA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 240 k |
|
79
|
304
|
7lcpA |
N-terminal finger stabilizes feline drug gc376 in coronavirus 3cl protease |
|
70
|
306
|
7mhpA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k at high humidity |
|
82
|
306
|
7mhhA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 277 k |
|
87
|
306
|
7mhfA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 100 k |
|
76
|
306
|
7mhlA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 100 k |
